AllGen Financial Advisors Inc. Has $2.12 Million Holdings in Becton, Dickinson and Company (NYSE:BDX)

AllGen Financial Advisors Inc. lifted its position in shares of Becton, Dickinson and Company (NYSE:BDX) by 0.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,698 shares of the medical instruments supplier’s stock after purchasing an additional 59 shares during the quarter. Becton, Dickinson and Company accounts for 1.1% of AllGen Financial Advisors Inc.’s investment portfolio, making the stock its 23rd largest holding. AllGen Financial Advisors Inc.’s holdings in Becton, Dickinson and Company were worth $2,121,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. OFI Invest Asset Management acquired a new stake in shares of Becton, Dickinson and Company in the 3rd quarter worth about $25,000. DiNuzzo Private Wealth Inc. bought a new position in shares of Becton, Dickinson and Company in the fourth quarter valued at approximately $30,000. Fortitude Family Office LLC purchased a new position in shares of Becton, Dickinson and Company during the fourth quarter valued at approximately $35,000. Venturi Wealth Management LLC boosted its position in shares of Becton, Dickinson and Company by 552.0% during the fourth quarter. Venturi Wealth Management LLC now owns 163 shares of the medical instruments supplier’s stock valued at $40,000 after buying an additional 138 shares during the last quarter. Finally, Arlington Trust Co LLC bought a new stake in Becton, Dickinson and Company during the fourth quarter worth $41,000. 86.97% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Barclays lifted their price objective on shares of Becton, Dickinson and Company from $301.00 to $305.00 and gave the stock an “overweight” rating in a report on Monday, February 5th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $280.00.

Insiders Place Their Bets

In other news, EVP Michael David Garrison sold 1,715 shares of the company’s stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $232.81, for a total transaction of $399,269.15. Following the transaction, the executive vice president now owns 5,381 shares of the company’s stock, valued at approximately $1,252,750.61. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Michael David Garrison sold 1,715 shares of Becton, Dickinson and Company stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $232.81, for a total value of $399,269.15. Following the completion of the transaction, the executive vice president now owns 5,381 shares in the company, valued at $1,252,750.61. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Thomas J. Spoerel sold 282 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $238.29, for a total transaction of $67,197.78. Following the completion of the sale, the senior vice president now directly owns 2,276 shares in the company, valued at approximately $542,348.04. The disclosure for this sale can be found here. Company insiders own 0.31% of the company’s stock.

Becton, Dickinson and Company Stock Performance

BDX stock traded down $5.67 during midday trading on Friday, hitting $234.68. The company’s stock had a trading volume of 1,722,353 shares, compared to its average volume of 1,291,373. The stock has a market cap of $67.80 billion, a price-to-earnings ratio of 51.69, a PEG ratio of 1.93 and a beta of 0.45. The company has a quick ratio of 0.64, a current ratio of 1.41 and a debt-to-equity ratio of 0.62. The stock’s 50-day moving average price is $238.45 and its 200 day moving average price is $240.27. Becton, Dickinson and Company has a 1 year low of $229.40 and a 1 year high of $287.32.

Becton, Dickinson and Company (NYSE:BDX) last issued its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.97 by $0.20. Becton, Dickinson and Company had a net margin of 6.76% and a return on equity of 13.90%. The company had revenue of $5.05 billion for the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the previous year, the firm earned $2.86 EPS. The firm’s quarterly revenue was up 4.6% on a year-over-year basis. On average, equities analysts forecast that Becton, Dickinson and Company will post 13.04 EPS for the current year.

Becton, Dickinson and Company Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Monday, June 10th will be paid a $0.95 dividend. The ex-dividend date is Monday, June 10th. This represents a $3.80 annualized dividend and a yield of 1.62%. Becton, Dickinson and Company’s payout ratio is 83.70%.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.